Strumento inattivo

Altre lingue PFIZER Euronext Paris

Azioni

Prezzo di chiusura Euronext Paris Altri mercati azionari
-	-

31/05	Aggiornamento settoriale: titoli del settore sanitario in rialzo nel tardo pomeriggio	MT
31/05	Aggiornamento settoriale: i titoli del settore sanitario avanzano venerdì pomeriggio	MT

Sector Update: Health Care Stocks Higher Late Afternoon	31/05
Sector Update: Health Care Stocks Advance Friday Afternoon	31/05
Sector Update: Health Care	31/05
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug	31/05
US FDA approves Moderna's RSV vaccine, its second marketed product	31/05
Pfizer Says Lorbrena Shows Positive Long-Term Results in Advanced Lung Cancer Patients	31/05
BioNTech gets $145 mln funding for African vaccine plants	29/05
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants	29/05
Usa e Paesi europei considerano vaccinazione per lavoratori esposti a influenza aviaria	27/05
US, European nations consider vaccinating workers exposed to bird flu	27/05
Novavax awaits FDA decision on whether its next COVID shot can be offered in US	24/05
Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief	23/05
BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi	23/05
Asymchem Laboratories Buys Pfizer's Former UK Site; Hong Kong Shares Slide 3%	23/05
US IS IN 'ACTIVE CONVERSATIONS' WITH MRNA VACCINE MAKERS PFIZER…	22/05
Sector Update: Health Care Stocks Slightly Higher Late Afternoon	22/05
Sector Update: Health Care	22/05
Pfizer Looks for $1.5 Billion in Savings by 2027, Expects One-Time Cost Reduction Charge of $1.7 Billion	22/05
Pfizer targets $1.5 bln in savings by 2027 as it streamlines operations	22/05
Pfizer launches multi-year cost-cuts program, eyes $1.5 bln in savings	22/05

Non ci sono risultati per questa ricerca

Pfizer, Inc: un ciclo per niente?

15 dicembre 2023 alle 18:26

Il CEO di Pfizer su vendite, M&A, mRNA, farmaco per la perdita di peso